FindTrial
Sign In

The effectiveness and safety of novel interventional techniques in the treatment of lower limb arteriosclerosis obliterans

The effectiveness and safety of novel interventional techniques in the treatment of lower limb arteriosclerosis obliterans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078978
Enrollment
Unknown
Registered
2023-12-22
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans of lower limbs

Interventions

Control group:Balloon dilatation and endovascular stents
Experimental group:Directional atherectomy and drug-coated ballon dilation

Sponsors

Beijing Chaoyang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 18-85 years old; Diagnosed with atherosclerotic obliteration of lower limbs, and Rutherford grading is 3-5 Severe stenosis, occlusion, or ISR>50% in the lower limb arteries confirmed by CTA or angiography

Exclusion criteria

Exclusion criteria: Expected life<1 year Serious health events, including but not limited to myocardial infarction, stroke, severe liver and/or kidney dysfunction, and coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Survival without amputation;—

Secondary

MeasureTime frame
Success rate of operation;Primary patency;Pain score;Recurrence rate ;Mortality;Ankle brachial index ;Amputation rate;—

Countries

China

Contacts

Public ContactChunmin Li

Beijing Chaoyang Hospital Affiliated to Capital Medical University

lcmbs@126.com+86 188 0107 3795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026